About IMCI Pharmaceuticals

Who We Are?

IMCI is a pharmaceutical company that develops cannabis-based medicines to treat neuropathic pain.
 

To assume its vision at an affordable price, IMCI operates a full value-chain of pharmaceutical cannabis-based production under SA & EU-GMP standards from seed to final product.

 

IMCI R&D is based in Israel while its operation locates in South Africa and target the African and the EU markets.

Vertically-Integrated Operation

Full value chain from Seed to Final product

Full value chain operation.jpg
 

Our Vision

To become a leading pharmaceutical company, who will develop pharmaceutical cannabis-based novel medicines and medical pharma-grade products to treat neuropathic pain in prevalent health conditions at an affordable price.